Diabetes and Metabolic market research in India

India's healthcare market is shaped by the world's largest generics industry, Hyderabad's Genome Valley, the Mumbai and Ahmedabad pharma belts and fast-growing private hospital chains. Diabetes and Metabolic companies operating here need research that reflects local clinical practice, CDSCO requirements and how reimbursement actually works.

We recruit diabetes and metabolic stakeholders across Pune, Mumbai, Delhi NCR, New Delhi, Bengaluru, Hyderabad, Chennai, Ahmedabad, Kolkata, Gurugram, Noida, Navi Mumbai, Thane, Kochi, Chandigarh, Jaipur, Lucknow, Indore, Nagpur, Vadodara, Coimbatore, Visakhapatnam, Bhubaneswar, Thiruvananthapuram, Mysuru, Surat, Goa, Nashik, Aurangabad, Kolhapur, Solapur, Rajkot, Bhopal, Gwalior, Jabalpur, Raipur, Ranchi, Patna, Guwahati, Shillong, Dehradun, Haridwar, Shimla, Amritsar, Ludhiana, Jalandhar, Mohali, Panchkula, Faridabad, Ghaziabad, Meerut, Agra, Kanpur, Varanasi, Prayagraj, Jodhpur, Udaipur, Ajmer, Kota, Madurai, Tiruchirappalli, Salem, Vellore, Puducherry, Mangaluru, Hubballi, Belagavi, Vijayawada, Guntur, Tirupati, Warangal, Nellore, Kozhikode, Thrissur, Cuttack, Jamshedpur, Dhanbad, Siliguri, Durgapur, Jammu, Srinagar, Gandhinagar, Anand, Vapi, Bhavnagar, Aligarh, Bareilly, Gorakhpur, Navsari, Sangli, Ahmednagar, Amravati, Akola, Jalgaon, Baddi, Gangtok, Imphal, Agartala, Silvassa, Hosur, then design and analyse every study at our India headquarters with senior oversight.

Focus areas in India

• GLP-1 adoption in India
• CGM use in India
• Primary care in India
• Patient adherence in India

See all healthcare market research in India.